Literature DB >> 23579057

Mesenchymal stromal cells: heroes or non-combatants?

Shoba Amarnath1, Austin J Barrett.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23579057      PMCID： PMC3699188          DOI： 10.1016/j.jcyt.2013.01.001

Source DB:  PubMed          Journal:  Cytotherapy        ISSN： 1465-3249            Impact factor:   5.414


× No keyword cloud information.
  14 in total

1.  Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34(+) cells in NOD/SCID mice.

Authors:  Willy A Noort; Alwine B Kruisselbrink; Pieternella S in't Anker; Marjolein Kruger; Rutger L van Bezooijen; Roelf A de Paus; Mirjam H M Heemskerk; Clemens W G M Löwik; J H Falkenburg; Roel Willemze; Willem E Fibbe
Journal:  Exp Hematol       Date:  2002-08       Impact factor: 3.084

2.  Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex.

Authors:  K Le Blanc; L Tammik; B Sundberg; S E Haynesworth; O Ringdén
Journal:  Scand J Immunol       Date:  2003-01       Impact factor: 3.487

3.  Bone marrow mesenchymal stem cells suppress lymphocyte proliferation in vitro but fail to prevent graft-versus-host disease in mice.

Authors:  Muriel Sudres; Françoise Norol; Aurélie Trenado; Sylvie Grégoire; Frédéric Charlotte; Béatrice Levacher; Jean-Jacques Lataillade; Philippe Bourin; Xavier Holy; Jean-Paul Vernant; David Klatzmann; José L Cohen
Journal:  J Immunol       Date:  2006-06-15       Impact factor: 5.422

4.  Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo.

Authors:  Amelia Bartholomew; Cord Sturgeon; Mandy Siatskas; Karen Ferrer; Kevin McIntosh; Sheila Patil; Wayne Hardy; Steve Devine; David Ucker; Robert Deans; Annemarie Moseley; Ronald Hoffman
Journal:  Exp Hematol       Date:  2002-01       Impact factor: 3.084

5.  Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli.

Authors:  Massimo Di Nicola; Carmelo Carlo-Stella; Michele Magni; Marco Milanesi; Paolo D Longoni; Paola Matteucci; Salvatore Grisanti; Alessandro M Gianni
Journal:  Blood       Date:  2002-05-15       Impact factor: 22.113

6.  Co-infusion of ex vivo-expanded, parental MSCs prevents life-threatening acute GVHD, but does not reduce the risk of graft failure in pediatric patients undergoing allogeneic umbilical cord blood transplantation.

Authors:  M E Bernardo; L M Ball; A M Cometa; H Roelofs; M Zecca; M A Avanzini; A Bertaina; L Vinti; A Lankester; R Maccario; O Ringden; K Le Blanc; R M Egeler; W E Fibbe; F Locatelli
Journal:  Bone Marrow Transplant       Date:  2010-04-19       Impact factor: 5.483

7.  Regulatory T cells and human myeloid dendritic cells promote tolerance via programmed death ligand-1.

Authors:  Shoba Amarnath; Carliann M Costanzo; Jacopo Mariotti; Jessica L Ullman; William G Telford; Veena Kapoor; James L Riley; Bruce L Levine; Carl H June; Timothy Fong; Noel L Warner; Daniel H Fowler
Journal:  PLoS Biol       Date:  2010-02-02       Impact factor: 8.029

8.  IFN-gamma activation of mesenchymal stem cells for treatment and prevention of graft versus host disease.

Authors:  David Polchert; Justin Sobinsky; Gw Douglas; Martha Kidd; Ada Moadsiri; Eduardo Reina; Kristyn Genrich; Swati Mehrotra; Suman Setty; Brett Smith; Amelia Bartholomew
Journal:  Eur J Immunol       Date:  2008-06       Impact factor: 5.532

9.  Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study.

Authors:  Katarina Le Blanc; Francesco Frassoni; Lynne Ball; Franco Locatelli; Helene Roelofs; Ian Lewis; Edoardo Lanino; Berit Sundberg; Maria Ester Bernardo; Mats Remberger; Giorgio Dini; R Maarten Egeler; Andrea Bacigalupo; Willem Fibbe; Olle Ringdén
Journal:  Lancet       Date:  2008-05-10       Impact factor: 79.321

10.  Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation.

Authors:  Lynne M Ball; Maria Ester Bernardo; Helene Roelofs; Arjan Lankester; Angela Cometa; R Maarten Egeler; Franco Locatelli; Willem E Fibbe
Journal:  Blood       Date:  2007-07-16       Impact factor: 22.113
View more
  1 in total

1.  Bone marrow-derived mesenchymal stromal cells harness purinergenic signaling to tolerize human Th1 cells in vivo.

Authors:  Shoba Amarnath; Jason E Foley; Don E Farthing; Ronald E Gress; Arian Laurence; Michael A Eckhaus; Jean-Yves Métais; Jeremy J Rose; Frances T Hakim; Tania C Felizardo; Austin V Cheng; Pamela G Robey; David E Stroncek; Marianna Sabatino; Minoo Battiwalla; Sawa Ito; Daniel H Fowler; Austin J Barrett
Journal:  Stem Cells       Date:  2015-04       Impact factor: 6.277
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.